InsidersTradesSigma
Track the Biocon share price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €669.9bn. The latest transaction was disclosed on 31 July 2026 (Disposal). Among the most active insiders: Mylan Inc.. All data is accessible without an account.
Analysts rate Biocon Hold (neutral), based on 20 analysts. Average price target: ₹439.05.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Biocon is an Indian biopharmaceutical company focused on the research, development, and manufacturing of medications. It specializes in oncology, diabetes, and autoimmune diseases.